期刊文献+

EZH2、P57^(Kip2)在舌鳞状细胞癌中的表达及意义 被引量:1

The expression and significance of EZH2 and P57^(Kip2) in human tongue squamous cell carcinoma
下载PDF
导出
摘要 目的:研究EZH2和P57Kip2在舌鳞癌中的表达情况及其临床意义。方法:应用免疫组化Envision法检测61例舌鳞癌、10例非肿瘤舌黏膜中EZH2和P57Kip2的表达,分析其与临床病理学参数的关系。结果:EZH2和P57Kip2在舌鳞癌中的表达阳性率分别为77.0%和27.9%,在非肿瘤舌黏膜中的阳性率分别为20%和100%。EZH2、P57Kip2与舌鳞癌的病理学分级、临床分期及淋巴结转移相关(P<0.05)。在舌癌中,EZH2与P57Kip2表达呈负相关(P<0.01)。结论:EZH2和P57Kip2在舌鳞癌的发生及发展中以相反机制发挥重要作用。 Objective:To investigate the expression and clinical significance of EZH2 and P57Kip2 in tongue squamous cell carcinoma (TSCC).Methods:The expression of EZH2 and P57Kip2 in 61 cases of TSCCs and 10 cases of non-cancerous mucosa of tongue(control) was measured by immunohistochemistry Envision method.The relationship between the expression of clinicopathological parameters and EZH2 or P57Kip2 was analyzed.Results:The positive expression rates of EZH2 and P57Kip2 in TSCCs were 77.0% and 27.9%,in the controls were 20% and 100%,respectively.The expression of EZH2 and P57Kip2 was correlated to TSCCs pathological grades,clinical stages and lymphatic metastasis(P < 0.05).In TSCC group,there was negative correlation between the expression of EZH2 and P57Kip2 (P < 0.01).Conclusion:EZH2 and P57Kip2 protein may play an important role in the carcinogenesis and progression of TSCC in a contrary manner.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2013年第6期837-840,共4页 Journal of Practical Stomatology
基金 江西省教育厅科学技术研究项目(编号:GJJ11330)
关键词 EZH2 P57KIP2 舌鳞状细胞癌 EZH2 P57Kip2 Tongue squamous cell carcinoma
  • 相关文献

参考文献11

  • 1岳增文,曹选平,王树斌,张克.SPHK1在舌鳞癌中的表达及其表达下调对Tca8113细胞迁移能力的影响[J].实用口腔医学杂志,2012,28(6):735-739. 被引量:7
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 3Kuzmichev A ,Jenuwein T,Tempst P, et al. Different EZH2- containing complexes target methylation of histone H1 or nu- cleosomal histone H3 [ J ]. Mol Cell, 2004,14 (2) : 183 - 193.
  • 4Bracken AP, Pasini D, Capra M, et al. EZH2 is down- stream of the pRB-E2F pathway, essential for proliferation and amplified in cancer[ J ]. EMBO J, 2003, 22 (20) :5323 - 5235.
  • 5Visser HP, Gnnster MJ, Klnin-Nelemans HC, et al. The Polycomb group protein EZH2 is upregulated in prolifera- ting, cultured human mantle cell lymphoma [ J ]. Br J Haematol, 2001, 112(4) :950 -958.
  • 6Kidani K, Osaki M, Tamura T, et al. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas. [ J]. Oral Oncol, 2009,45( 1 ) :39 -46.
  • 7Ito Y, Takeda T, Wakasa K, et al. Expression of p57/Kip2 protein in pancreatic adenocarcinoma [ J ]. Pancreas, 2001, 23(3) :246 -250.
  • 8Yamamoto T, Digumarthi H, Aranbayeva Z, et al. EGCG- targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: Role of c-Jun N-terminal kinase [ J]. Toxicol Appl Pharmacol, 2007, 224(3) :318 - 325.
  • 9Shin JY, Kim HS, Park J, et al. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer ceils [ J ]. Cancer Res, 2000,60 ( 2 ) : 262 - 265.
  • 10Yang X, Karuturi RK, Sun F, et al. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigeneti~: mechanisms in breast cancer cells [ J ]. PLoS One, 2009,4 (4) :e5011.

二级参考文献18

  • 1赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 2谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 3Jemal A, Siegel R, Xu J, et al. Caneer statistics, 2010 [J]. CA CancerJ Clin, 2010, 60(5) :277 -300.
  • 4Shiboski CH, Sctmlidt BL, Jordan RC. Tongue and tonsil carcinoma- Increasing trends in the U. S. Population ages 20-44 years [ J ]. Cancer, 2005, 103 (9) : 1843 - 1849.
  • 5Pyne S, Lee SC, Long J, et al. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spalial sphingosine 1-phosphate signalliug ilk health and disease [J]. Cell Signal, 2009, 21(1):14-21.
  • 6French KJ, Schrecengosl RS, Lee BD. et al. Discovery and evaluation of inhibitors of human sphingosine kinase [ J ]. Cancer Res, 2003, 63 ( 18 ) :5962 - 5969.
  • 7Johnson KR, Johnson KY, Crellin HG, et al. lmmunohislo- (!heroical distribution of sphingosine kinase 1 in normal an(] tumor lung tissue[ J ]. J Histochem Cytochem, 2005, 53 (9) :1159 -1166.
  • 8Kawamori T, Osta W, Johnson KR, et al. Sphingosine ki- nase 1 is up-regulated in colon carcinogenesis[ J]. FASEB J, 2006, 20(2) :386 -388.
  • 9Liu H, Shi G, Liu X, et al. Overexpression of Tiaml pre- dicts poor prognosis in patients with esophageal squamous cell eareinoma[J] Onc:ol Rep, 2011, 25(3):841 -848.
  • 10Xia P, Gamble JR, Wang I,, el al. An oncogenic role of sphingosine kinase[J]. Curt Biol, 2000, 10(23) :1527 - 1530.

共引文献1370

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部